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Abstract
Background: Microenvironment cues involved in melanoma progression are largely unknown. Melanoma is highly
influenced in its aggressive phenotype by the changes it determinates in its microenvironment, such as pH decrease,
in turn influencing cancer cell invasiveness, progression and tissue remodelling through an abundant secretion of
exosomes, dictating cancer strategy to the whole host. A role of exosomes in driving melanoma progression under
microenvironmental acidity was never described.
Methods: We studied four differently staged human melanoma lines, reflecting melanoma progression, under
microenvironmental acidic pHs pressure ranging between pH 6.0–6.7. To estimate exosome secretion as a
function of tumor stage and environmental pH, we applied a technique to generate native fluorescent
exosomes characterized by vesicles integrity, size, density, markers expression, and quantifiable by direct
FACS analysis.
Functional roles of exosomes were tested in migration and invasion tests. Then we performed a comparative proteomic
analysis of acid versus control exosomes to elucidate a specific signature involved in melanoma progression.
Results: We found that metastatic melanoma secretes a higher exosome amount than primary melanoma, and that
acidic pH increases exosome secretion when melanoma is in an intermediate stage, i.e. metastatic non-invasive.
We were thus able to show that acidic pH influences the intercellular cross-talk mediated by exosomes. In fact when
exposed to exosomes produced in an acidic medium, pH naïve melanoma cells acquire migratory and invasive capacities
likely due to transfer of metastatic exosomal proteins, favoring cell motility and angiogenesis.
A Prognoscan-based meta-analysis study of proteins enriched in acidic exosomes, identified 11 genes (HRAS, GANAB,
CFL2, HSP90B1, HSP90AB1, GSN, HSPA1L, NRAS, HSPA5, TIMP3, HYOU1), significantly correlating with poor prognosis,
whose high expression was in part confirmed in bioptic samples of lymph node metastases.
Conclusions: A crucial step of melanoma progression does occur at melanoma intermediate –stage, when extracellular
acidic pH induces an abundant release and intra-tumoral uptake of exosomes. Such exosomes are endowed with pro-
invasive molecules of clinical relevance, which may provide a signature of melanoma advancement.
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Background
In melanoma cell systems, progression of tumorigenesis is
influenced by changes of microenvironmental conditions
in pre-malignant lesions. They involve complex interac-
tions with surrounding structural endothelial cells, which
ultimately lead to hypoxia and extracellular acidity.
Microenvironmental acidification is the consequence of
an upregulated glycolysis which results in acute and chronic
pH decrease of the local microenvironment, that in human
melanoma has been reported to be about 6.4–7.3 [1, 2].
In the early phases of tumor progression, extracellular
acidity influences gene expression by up modulation of sev-
eral hundred genes encoding receptors, signal proteins,
transcription factors, cytokines [3], involved in invasion, tis-
sue remodeling, cell cycle control and proliferation [4, 5],
thus leading to a more malignant cell phenotype.
However, microenvironment cues involved in the early
steps of melanoma progression are largely unknown. Exo-
somes, 50–100 nm vesicles abundantly released into the
extracellular space [6], represent an important source of
information with respect to the pH variations in melan-
oma. In fact, it has been established that exosomes mirror
the signaling molecules content of cell from which they
are generated, and are able to shuttle in an autocrine or
paracrine way their molecular content from donor to re-
cipient cells [7]. Exosomes can also use distal endocrine
modality to interfere with phenotype and cellular pro-
cesses of target cells, playing multiple roles in tumor pro-
gression including enhanced immunosuppression [8],
angiogenesis [9], and metastasis by conditioning bone
marrow and pre metastatic niches [10–12].
A recent study reported that conditioned medium by
acidic melanoma cells promoted invasiveness and lung
metastasis development of non acidic tumor cell [13].
However, a role of exosomes secreted under microenvir-
onment acidic pressure in promoting melanoma pro-
gression was not described so far.
Tumor cells constitutively release in the microenviron-
ment a plethora of extracellular vesicles (EV) other than
exosomes, (i.e. microparticles, oncosomes) of plasma
membrane origin with totally different roles [14], that are
co-isolated in all the most common procedures including
ultracentrifugation. In fact, as recently reported, vesicles
obtained by ultracentrifugation are endowed with markers
of plasma membrane or endosome origin [15, 16].
Therefore, the lack of an elective procedure to monitor
only the traffic of the entire exosome population has inter-
fered so far with clear assessment of exosomes involve-
ment in biological processes. In fact, also the exosome
antigen-bead isolation and intracellular visualization
methods (CD63, CD81, CD9) allowed the study of sub
populations, without taking into account vesicles hetero-
geneity and consequent limited role in biological processes
observed in vitro [17].
In this paper we used a procedure based on the gener-
ation of metabolically labelled 100 nm -sized vesicles of
endosomal origin [18]. This was made possible by add-
ing in cell cultures a fatty acid analogue (Bodipy FL
-C16), that upon uptake enters in cellular lipid metabol-
ism ultimately producing fluorescent exosomes (C16-
exo). After isolation from culture supernatants, these
exosomes can be rapidly examined and quantified by
direct FACS analysis. Importantly, this method repre-
sents an improvement on exosomes FACS-based studies
so far reported, and provides a quantitative correlation
between exosome uptake and cell functional effects. By
means of this procedure we elucidated a role of micro-
environment acidity in melanoma progression. We eval-
uated exosome release under acidic pH pressure from
four differently staged human melanoma cell lines, rep-
resentative of various steps of melanoma development.
The extracellular pH in the central region of tumors
decreases at pH 6.7 and below because of lactate accu-
mulation [1, 19, 20]. In order to mimic this process in
vitro, we lowered the pH in cell culture media to pH 6.7
or 6.0, and evaluated the exosome population by FACS
quantification, markers expression and density
evaluation.
Next, we set up in vitro functional studies on acid
pH-responsive metastatic non invasive (MNI) cell line,
and performed a comparative proteomic characterization
of exosomes obtained from standard and acid cell culture.
The proteome expression in acid condition indicated an
upregulation of several proteins belonging to functional
categories previously described in melanoma progression
such as proteoglycans, focal adhesion and protein process-
ing in endoplasmic reticulum [21–23].
To find a clinical relevance of our proteomic studies,
we examined human epidemiological data using the
PrognoScan database [24], a large collection of publicly
available cancer microarray datasets with clinical correl-
ation in melanoma patients. The resulting data was fi-
nally validated by IHC on bioptic samples.
Methods
Cell lines
We analyzed some human melanoma cell lines represen-
tative of various degree of malignancy. Specifically we
utilized WM115 (PI) and WM266–4 (MI) commercially
available, that upon arrival were expanded, freezed and
stored under liquid nitrogen. Me1007 (EP) and Mel501
(MNI) were obtained by Istituto Nazionale Tumori
(Milan, Italy), authenticated according to a standard
short tandem repeat-based genotyping at Ospedale Poli-
clinico San Martino (Genova, Italy), and periodically
tested for mycoplasma contamination.
Mel501 represents a primary low invasive melanoma
and Me1007 an early primary melanoma. WM115 is a
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primary invasive and WM266–4 an advanced metastatic
melanoma obtained from the same patient. Me1007 and
Mel501 carry no classical mutations, whereas the other
cell lines are B-RAF mutated (V600D) (Additional file 1).
Melanoma cells were cultured in RPMI-1640 or Dulbecco
modified Eagle’s medium (DMEM) (GIBCO by Life Tech-
nologies) supplemented with 10% fetal calf serum (FCS),
in a humidified 5% CO2 incubator.
The bioptic melanoma specimens used in this study
were obtained from the archives of the Istituto Dermo-
patico dell’Immacolata-IRCCS (Rome-Italy). Signed in-
formed consent was obtained from patients. For each
patient, melanoma samples (primary and autologous me-
tastasis) were analyzed. Sampling and handling of hu-
man tissue material were carried out in accordance with
the ethical principle of the Declaration of Helsinki.
Cell labelling with BodipyFL-C16, and acidic treatments
MNI and EP cells (50% confluence) were incubated with
Bodipy FL -C16 (4,4-difluoro-5,7-dimethyl-4-bora-3a,4a--
diaza-s-indacene-3-hexadecanoic acid) (C16) (Life Tech-
nologies) by addition of 7 μM C16 in medium
supplemented with 0.3% FCS for 4 h at 37 °C, as previ-
ously described [18].
The culture media at various pHs were obtained as fol-
lows. For pH 6.7 condition, we minimized the pH change
during the cell culture by addition of 20 mM MOPS
(3-(N-morpholino) propanesulfonic acid) to medium con-
taining FBS, then adjusted with 1 N HCL to pH 6.7. A
stronger acid condition (pH 6.0) was obtained by the
addition of 1 N HCl to medium containing FBS. After
24 h incubation pH was evaluated by pH -meter and
found unchanged for pH 6.7 condition, whereas in pH 6.0
samples, pH value ranged between 6.1–6.3.
Isolation of C16-exo
C16-exo recovery was performed as previously described
[7, 18] by ultracentrifugation method with minor modifi-
cations (Additional file 2).
Western blot
Western blot analysis was performed according to stand-
ard procedures. C16-exo and melanoma cells were resus-
pended in Laemmli sample buffer with freshly added
50 μM DTT. Antibodies listed below were used in ac-
cordance to the manufacturer’s instructions: Mouse
monoclonal antibody to Alix (3A9 #MA183977, Thermo
Scientific, Waltham, MA USA); Mouse monoclonal anti-
body to TSG101 (4A10 #GTX70255, GeneTex, Irvine,
CA USA); Mouse monoclonal antibody to Calnexin (37/
Calnexin #610524, BD Transduction Laboratories, Lex-
ington, KY USA), Mouse monoclonal antibody to CD81
(B11 #sc166029, Santa Cruz Biotechnology, Dallas, TX
USA), Mouse monoclonal antibody to Flotillin-1 (18/
flotillin-1 #610821 BD Transduction Laboratories, San
Josè, CA USA), Mouse monoclonal antibody to Hsp70
(3A3 #NB6001469, Novus Biologicals, Littleton, CO
USA), Rabbit polyclonal antibody to HSP90α/β (H114
#sc7947, Santa Cruz Biotechnology, Dallas, TX USA),
Rabbit polyclonal antibody to Cofilin (#3312, Cell Signal-
ing Thechnology, Leiden, The Netherlands), Goat poly-
clonal antibody to Gelsolin (N-18 #sc6406, Santa Cruz
Biotechnology, Dallas, TX USA).
TLC analysis of fluorescent phospholipids
Fluorescent phospholipids were analyzed as described
(18). Briefly, total lipids were extracted according to Folch
procedure and analyzed by TLC. As solvent mixture we
used chloroform/methanol/32% ammonia (65:35:5, v/v)
[25]. For plate scanning see Additional file 3.
FACS analysis and quantification of C16-exo
The presence of discrete and intact fluorescent vesicles
in C16-exo pellet isolated by ultracentrifugation
(Additional file 2) was assessed by FACS analysis as re-
ported [18] (see Additional file 3).
Optiprep™ gradient centrifugation
We used a discontinuous iodixanol gradient floatation as
described [26] (Additional file 3). Refractive index of
each fraction was assessed with a refractometer (Carl
Zeiss) and the relative density was calculated using the
linear relationship between refractive index (η) and the
density (ρ) ρ = Aη- B, [27] . For FACS quantification,
2 μl of each fraction were resuspended with 200 μl PBS
and analysed as above described.
Mass spectrometry analysis and data processing
Exosomes (8 μg) obtained from ctr or pH 6.0-treated
MNI cells incubated for 24 h in absence of FCS, were
separated on precast 4–12% Bis-Tris Gels (Invitrogen)
and stained with Coomassie Colloidal Blue. Each lane
was cut into sequential 25 slices and treated as in [28]
(Additional file 3).
Three independent experiments were performed. We
identified in exo (pH 6.0) 212, 211 and 217 proteins, and
in exo (ctr) 194, 239 and 130 proteins. Only proteins
identified with two peptides in at least two experiments
were considered, and their abundances were estimated
by the normalized emPAInorm values according to
emPAInorm = emPAI/Σi emPAI; where i = 1,N and N is
the number of proteins [29]. Reproducibility assessments
were carried out in both cases (pH 6.0 and control), and
the two best correlated experiments (Pearson’s correl-
ation higher than 0.8) were considered to calculate the
averaged emPAInorm value (186 in pH 6.0 and 157 in the
control) (Additional file 3).
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The emPAInorm ratio (ρ) between emPAInorm values of
proteins identified in pH 6.0 and those identified in the
control was calculated. According with the emPAI ratio
proteins were classified as up-regulated in pH 6.0 (ρ ≥
1.5), equally regulated in pH 6.0 and in the control
(0.5 ≤ ρ ≤ 1.5) and down-regulated in pH 6.0 condition
(ρ ≤ 0.5).
Functional analysis was performed by using the DA-
VID Bioinformatics Resources 6.8 [30]. Proteins up-,
equally and down-regulated were mapped on KEGG
pathways separately and over-represented categories
(P ≤ 10− 2) were considered.
C16-exo transfer and functional assays
To evaluate C16-exo transfer to target cells, increasing
amounts (40 to 700 exosome per cell) of C16-exo (ctr),
C16-exo (pH 6.0) were added to MNI cells in a 96 well
plate in duplicate in 100 μl RPMI without serum and
kept for 2 h at 37 °C in incubator. Then medium was re-
moved, cells PBS-washed, detached and subjected to FC
analysis as described [18]. Briefly, fluorescence data of
C16-exo, cell samples, and Quantum
TM FITC-5 MESF
(Bangs Laboratories, Inc.) standard curve were acquired
and transformed into MESF (Molecules of Equivalent
Soluble Fluorophores) using the QuickCal analysis tem-
plate provided with each QuantumTM MESF lot. Then
MESF associated to cells were converted in number of
transferred exosomes according the formula: (cell fluor-
escence (MESF)-cell autofluorescence (MESF))/ exo-
some fluorescence (MESF).
Migration and invasion studies were performed ac-
cording to standard procedures.
Cell migration was assayed, as previously described
[31], using uncoated cell culture inserts (Corning Costar
Corporation, Cambridge, MA). Assays were incubated at
37 °C in 5% CO2, and after 72 h migration was evaluated
by a colorimetric assay [32] at 620 nm in a microplate
reader (Victor X3, Perkin Elmer). Invasion was evaluated
as for chemotaxis on culture inserts previously coated
with matrigel.
Cell viability was measured by exclusion of dead cells
with Trypan Blue Solution (0.4%).
Confocal microscopy
For Confocal Laser Scanner Microscopy (CLSM) ana-
lysis, cells were grown on sterilized coverslips for 24 h.
Cells were metabolically labeled with C16 or treated with
C16-exo, then fixed with paraformaldehyde (3%) (30 min,
4 °C), quenched with 10 mM NH4Cl and mounted on
the microscope slide with Vectashield antifade mounting
medium containing DAPI (Vector Laboratories, Burlin-
game, CA). For images captures see Additional file 3.
Meta-analysis of the prognostic value of gene expression
by PrognoScan
PrognoScan is a comprehensive online platform for
evaluating potential tumor biomarkers and therapeutic
targets [33].
Based on a large collection of cancer microarray data-
sets with clinical annotation on GEO databases [34],
PrognoScan is a tool to assess the association between
specific gene expression and prognosis in patients with
cancer [24].
We used this online database to validate metastasis-related
proteins found upregulated in acid exosomes with the rela-
tive gene expression in cancer tissue samples versus Overall
Survival (OS) rates of patients with metastatic melanoma
(Table 1).
Immunohistochemical staining
Tissue sections from primary cutaneous and metastatic
lymph node melanoma samples embedded in paraffin
were dewaxed and rehydrated. For immunolocalization
studies slides were first subjected to heat-mediated anti-
genic retrieval (10 mM Sodium Citrate buffer pH 6.0)
and then to melanin bleaching (warm 10% H2O2). Sub-
sequently slides were permeabilized (0.1% Triton X-100
for 10 min) and saturated (3% BSA for at least 2 h) at
RT. After incubation with primary antibody O/N at 4 °C
(anti GSN ab75832, 1:100, anti CFL AP08086PU-S Ori-
gene and anti HYOU1 ORP150/HSP12A NBP1–32140
Novus 1:50) in humidified chamber, slides were incu-
bated with specific fluorophore conjugated secondary
antibodies (Alexa Fluor, Molecular Probes Eugene, OR,
USA) for 45 min at RT. Ki67 (M7240 Clone MIB-1,
Dako) was used as positive immunostaining control.
Negative controls were performed by omission of the
primary antibody in each experiment. Finally, slides were
mounted with SlowFade anti-fade reagent containing
DAPI (Molecular Probes, Eugene, OR, USA) and ana-
lyzed by Olympus F1000 laser-scanning confocal micros-
copy (Olympus,Tokyo, Japan).
Statistical analysis
Differences were statistically evaluated using Student’s t
test. p < 0.05 was regarded as significant. In some experi-
ments one-way ANOVA multiple comparison analysis
with Tukey’s post test was used. For OS analysis,
Mentel-Cox p-values < 00.5 were considered as statisti-
cally significant.
Results
Effect of acidic pH on melanoma morphology
It is known that melanoma is able to grow in a context
of extracellular acidosis within the range of pH 6.4 to 7.3
[1, 2]. Trying to closely mimic in vitro the action of
tumor microenvironment, we cultured melanoma cells
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in acidified media at pH 6.7 and pH 6.0, and analyzed
the influence of these low pHs on differently staged mel-
anomas, specifically the early primary (EP) and the
metastatic non invasive (MNI) cell lines.
In line with previous study [4], microenvironmental
acidity did not modify cell viability, whereas it induced
in MNI cells a spindle shape morphology after 24 h in-
cubation, being cells significantly more elongated at
pH 6.0 and pH 6.7, when compared to controls grown at
standard conditions (Fig. 1 a, b, and Additional file 4).
Interestingly the EP melanoma morphology was not af-
fected by acidic pHs, thus likely indicating this early
stage to be less sensitive to pH variations.
Then we labeled MNI and EP melanomas with green
fluorescent hexadecanoic acid (Bodipy FL -C16), and an-
alyzed the intracellular distribution, before the isolation
of fluorescent exosomes from culture media. After 24 h
incubation either at pH 7.4 (ctr) or acidic pHs (pH 6.7
or pH 6.0), cell fluorescence appeared either diffuse in
the endoplasmic reticulum area or restricted in spots
(Fig. 1c), likely resembling ER/late endosomal/MVB
compartments [18]. Interestingly such fluorescence was
absent from plasma membrane and was not affected by
medium pH.
In line with the morphometric analysis, only MNI cells
appeared gradually elongated, i.e. responsive to acidic
pHs. Thus, we performed the following experiments on
MNI cells.
Next, to exclude the presence of lipid probe aggre-
gates, we checked the effective C16 incorporation and
transformation in cell major lipid classes and the effects,
if any, resulting from pH treatments. TLC analysis
showed the same amount of major membrane lipid clas-
ses independently from pH treatment (Additional file 5).
Biophysical and biochemical properties of C16-exo are not
affected by acidic pH
Fluorescent exosomes (C16-exo) were recovered from
MNI conditioned medium after 24 h cell culture accord-
ing to an ultracentrifugation-based protocol (Additional
file 2). The resulting pellet was directly analyzed by FACS,
and showed the presence of a single fluorescent popula-
tion indicated as C16-exo without any background noise
on FL1 channel, as depicted by R1 region of the PBS con-
dition (Fig. 2a). pH treatments did not alter biophysical
vesicles parameters, since C16-exo displayed homogeneous
fluorescence intensity (Fig. 2a, histograms).
A parallel TLC analysis of C16-exo confirmed the pres-
ence of fluorescent major membrane lipid classes, being
similar in composition, with slight differences in fluores-
cence intensities at low pHs (Additional file 5).
To gain insight into the quality of vesicles secreted at
acidic pHs we used a protein specific dye,
Carboxyfluoresceindiacetate succinimidyl ester
(CFDA-SE), generally used as marker of integrity of pro-
tein loaded vesicles [35].
To ensure that the vesicle esterase activity was not af-
fected by pH, we tested the cell esterase function after 24 h
of pH treatments. Cell fluorescence was not modified by
acidic pHs (Additional file 6). Vesicles pellet obtained from
MNI cells was incubated with CFDA-SE to obtain
CFSE-EV, as depicted in Additional file 6. FACS analysis in-
dicated the presence of a single population as for C16 label-
ling, and fluorescence intensity was not affected by pH
treatments (Additional file 6).
This result confirmed that vesicles secretion at acidic
pHs was referred to intact protein-loaded structures. To
confirm the identity of C16-exo population as exosomes,
we evaluated the co-occurrence of three main parameters:
fluorescent vesicles, density and expression of specific
markers after gradient flotation. To avoid the risk of arti-
facts deriving from osmotic damages to the vesicles, we
opted for an iodixanol gradient.
C16-exo isolated from untreated (ctr) or acid (pH 6.7,
pH 6.0)-treated MNI cells were subjected to 10–40%
density gradients. Results indicated in all conditions the
existence of a population mainly distributed in fractions
corresponding to flotation densities between 1.096 and
1.177 g/ml specific to exosomes [14] (Fig. 2b), and positive
for the well known exosome markers Tsg101, Alix,
HSP90, flotillin-1, and HSP70, [16, 36] (Fig. 2c).
In each condition, approximately 15% of C16-vesicles
floated at lighter densities (1.046–1.073 g/ml), and was
devoid of exosome markers, possibly indicating the ex-
istence of a lighter endosomal vesicle population with a
lower protein content.
Enhanced C16-exo secretion at acidic pH depends on
melanoma stage
The amount of secreted exosomes on the base of disease
stage in melanoma is still a question of debate. To ad-
dress this point, we used the above-described strategy by
comparing C16-exo secretion from four differently staged
melanoma cell lines, early primary (EP), metastatic
non-invasive (MNI), primary/invasive (PI) and meta-
static invasive (MI). To better define the stage of the
melanoma cell lines used, we summarized the classifica-
tion and gene mutations, and evaluated whether mole-
cules related to melanoma progression, such as E-, and
N-cadherin involved in epithelial-mesenchymal transi-
tion (EMT), Tyrosinase and AP2α were differently
expressed (Additional file 1 and Additional file 14). Re-
sults indicated the occurrence of EMT together with low
expressions of AP2α and Tyrosinase in PI and MI cells,
in line with an advanced tumor stage. On the contrary
EP and MNI being in a pre-EMT phase, showed a higher
expression of AP2α and Tyrosinase, thus indicating an
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earlier stage in tumor progression. Next, we evaluated to
what extent and at which disease stage acidic pH could
significantly influence exosome secretion.
C16-exo were recovered from melanoma cell lines cul-
tured at pHs 6.0 and 6.7 for 24 h and FACS counted.
The acidity of the medium significantly enhanced exo-
some secretion when compared to buffered medium
(ctr) in MNI cells.
On the contrary, acid treatment did not affect exo-
some release in EP melanoma (Fig. 3a). One explanation
might be that the acid treatment does not influence exo-
some secretion in early primary melanoma due to its in-
trinsic scarcely aggressive nature.
Same analyses conducted on PI and MI cell lines,
obtained from the same patient, confirmed the higher
exosome secretion in advanced versus primary mela-
nomas. Specifically, in standard culture condition MI
produced 50 exosome per cell versus 25 secreted by
PI, in line with its more aggressive nature (Fig. 3b).
However in this case acidic pH positively influenced
exosome release in primary, but not in metastatic cell
line. This suggests that acidic pH can affect exosome
secretion at a specific tumor developmental stage, i.e.
only when the massive secretion of specific molecules
is required for the spread of the tumor and the pro-
gression of the disease.
Accordingly, the pH-sensitive PI cell line is already
endowed with invasive capability, thus indicating a
more advanced stage with respect to EP not respon-
sive to acidic pH in terms of exosome release. The
identity of these vesicles as exosomes was confirmed
by the expression of the common exosome markers
Tsg101, Alix and CD81 and the absence of calnexin
(Fig. 3c, d) [37].
To investigate a potential trigger to enhance exosome
secretion we first evaluated intracellular exosomal
markers expression (Alix and Tsg101) in the acid
pH-responsive (MNI) and not responsive (MI) cell lines.
We found that Alix was significantly upregulated after
short time pH 6.0 exposure and decreased together with
Tsg101 after 24 h in MNI cells (Additional file 7), thus
suggesting the enhanced exosome release as the result of
Fig. 1 Effect of pH treatments on MNI and EP morphology and C16 intracellular distribution. MNI and EP cells were cultured with standard (ctr),
pH 6.7 or pH 6.0 culture media for 24 h. Analysis of cell elongation (a) and perimeter (b) was performed by the determination of Feret’s diameter
and cell perimeter of each cell displayed in Additional file 4. c MNI and EP cells were labeled with C16 for 5 h and incubated at the indicated pHs
for 24 h. Cells were afterwards fixed and analyzed by fluorescence under confocal microscopy. The nucleus was visualized with DAPI staining
(blue). Scale bars, 10 μm. ***: p < 0.0001
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an augmented biosynthesis. Interestingly, these markers
were found unchanged during 24 h acid treatment in MI
cells (Additional file 7), in line with their unresponsive-
ness to acid pH.
We further evaluated intracellular pH variations as re-
sponsible of augmented exosome release. In fact, it is
known that external pH acidification can induce varia-
tions in intracellular pH [38], favouring cell proliferation,
drug resistance and metastasis progression [5, 39]. Thus,
we checked the intracellular pH after 24 h acid pH treat-
ment in MNI and MI cells (Additional file 7). In basal
condition both cell lines displayed a pHi ranging be-
tween 6.8–6.9, that was slightly increased at pH 7.0 by
extracellular acidification only in MI cells. However, the
pHi of MNI cells was not affected by extracellular acid
pH, indicating that increased exosome secretion does
not correlate with intracellular pH variations.
Altogether, these findings suggest that melanoma stage
is an important requisite for acidic pH-responsiveness,
that is mediated by an increase in exosome biosynthesis
and release.
Acid C16-exo induces migration and invasion
Increase in cell migration and invasion is hallmark of
tumor advancement [40]. To evaluate whether acid
exosomes could play a role in melanoma progression,
we performed a set of experiments on pH-sensitive
metastatic not invasive melanoma.
Thus we first determined the rate of control and acid
exosome uptake measured as number of vesicles trans-
ferred in target cells at pH 7.4. Results indicated a
slightly higher transfer efficiency of acid C16-exo
(pH 6.0), that was constantly reproduced at increasing
vesicle doses (Fig. 4a). Both classes of captured exo-
somes were visible in cytoplasmic area around nucleus
(Fig. 4b-c), and their transfer was influenced by extracel-
lular pH. In fact, both classes of exosomes were more ef-
ficiently transferred at extracellular acid pHs (Additional
file 8), with the exception of acid exosomes on cells at
pH 6.0. In particular, the acid exosome uptake at pH 6.0
was significantly lower of control exosomes uptake at
pH 7.4, thus further accounting for the greater extracel-
lular availability of acid exosomes above reported.
Interestingly, in EP cells the rate of control and acid
exosomes was similar and the amount of acid exosomes
transfer was not influenced by extracellular pH
(Additional file 8),
Next, the functional role of control and acid exo-
somes from MNI cells was explored through in vitro
migration and invasion assays. MNI melanoma cells
Fig. 2 FACS analysis of C16-exo and distribution on iodixanol gradient. a FACS analysis of C16-exo deriving from MNI cells cultivated with medium at
different pHs To design the R1 region above instrument background noise only PBS was acquired (upper panel). Note that no events were acquired in
this region. (mid panel) example of exosome population. (Lower panel) Histograms representing the green fluorescence intensity distribution of events
gated in R1 regions of exosome samples recovered in control, pH 6.7 and pH 6.0 conditions b C16-exo (ctr) (2,5 × 10
8), C16-exo (pH 6.7) (1,8 × 10
8), C16-
exo (pH 6.0) (2,5 × 108), were loaded at the bottom of iodixanol gradient and subjected to ultracentrifugation for 19 h. For each condition, 2 μl of
resulting fractions were FACS counted and each fraction represented as percent of total C16-exo recovered. Fraction densities were determined by
refractometry. c An equal volume of each fraction was analyzed for the indicated exosome markers by western blotting. Data shown are
representative of three independent experiments
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were incubated for 72 h with the same amount of
exosomes (1 × 107) released from control or
pH 6.0-cultured cells. The significant increase in cell
migration and invasion observed after uptake of acid
C16-exo (Fig. 4d), raised the hypothesis that a specific
molecular content could be responsible of cell ac-
quired aggressiveness.
To exclude the enhanced cell migration and invasion
as the result of increased proliferation, we examined the
effects of C16-exo (ctr) and C16-exo (pH 6.0) on MNI
cell growth. After 72 h incubation, cell proliferation was
not affected upon exosome treatments either in time
and dose-response experiments (Fig. 4e, f ).
To address whether these results could mirror the in
vivo process where a slow acclimation at low pH is
required to select resistant cells [4], we subjected MNI
cells to a two months low pH culture, followed by
1 month re-acclimation at physiological pH (Additional
file 9). In line with 24 h pH 6.0 treatment, we observed
an elongated cell morphology, and acquired migratory
ability in acid selected condition. Exosomes obtained
from acid selected cells induced migration in control
cells, thus confirming a stable pro-migratory role exerted
by acid microenvironment through exosomes.
Acid exosomes display an enrichment in metabolic
pathways related to tumor aggressiveness
Looking for the different molecular cargos potentially re-
sponsible of the newly acquired metastatic properties,
we investigated the protein composition of exosomes se-
creted by MNI cells under acidic pressure through a
label-free quantitative proteomics.
Exosomes recovered after 24 h of cell culture at acidic
(pH 6.0) and buffered (ctr) conditions were run on 4–12%
SDS-PAGE and subjected to in-gel trypsinization. The ex-
tracted peptides were then analyzed by Nano-RPLC. A
total number of 186 and 157 proteins were identified in
pH 6.0 and control samples, respectively.
The presence of 24 proteins (pH 6.0) and 21 proteins
(ctr) matching some of the most frequently identified
proteins within exosomes [41] further validated our
vesicle preparation (Additional file 10). Moreover, the
lack in our lists of melanosome markers, such as DCT
and GPNMB, excluded any possible contamination with
Fig. 3 Analysis of C16-exo secreted in control or acidic conditions. a and b EP, MNI, PI and MI cells were treated with C16 (7 μm) for 5 h and then
cultured in control or acid (pH 6.0 or pH 6.7) medium for 24 h. Hereafter conditioned medium was subjected to ultracentrifugation for exosome
isolation. Fluorescent vesicles were then counted by FACS. The graph shows the number of secreted C16-exo per cell. c and d Western blot analysis of
exosome for the presence of principal exosome markers (Alix, Tsg101 and CD81) and the absence of Calnexin, a marker of ER used as a negative
control. Data shown are representative of three independent experiments. * p < 0.05
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melanosomes, known to be abundantly secreted from
melanoma cells [42].
To gain insights into specific protein signature at
acidic pH, we generated three list of up-, equally and
down-regulated proteins in the pH 6.0 condition accord-
ing to the ratio of normalized emPAI values. We found
that 24 h cells incubation at low pH was sufficient to
modify exosome protein profile, being more than 50% of
the proteins up-regulated, as displayed by the compara-
tive Venn diagram (Fig. 5a).
Functional annotation analysis of these three data sets
was performed interrogating KEGG pathway database (Fig.
5b and Additional file 11). Interestingly, in acid conditions
functional categories, such as proteoglycans, focal adhesion
and protein processing in endoplasmic reticulum, respon-
sible for melanoma migration and invasion, metastasis and
survival [21–23], resulted over-represented.
Moreover, proteins related to melanogenesis were found
down-regulated in acid exosomes, thus confirming a cell
acquired more aggressive properties in line with a reduced
melanin content.
Further analyses by using Gene Ontology [43] con-
firmed the enrichment of acidic pH up-regulated pro-
teins in some key biological processes (Fig. 5c and
Additional file 12) as cell-cell adhesion, leukocyte migra-
tion, regulation of cell shape, small GTPase mediated
signal transduction, EGFR signaling pathways, all associ-
ated with the migratory properties of the cells.
Taken together, these results indicate that exosomes
released at low pH contain specific proteins that upon
transfer to recipient cells can mediate melanoma
malignancy.
Acid exosomes molecules profile reflects gene expression
in metastatic melanoma patients
To find a clinical relevance of modified exosome content at
acidic pH, we performed a meta-analysis of all the
metastasis-related functional categories listed in Additional
file 12, by using Prognoscan database [24] (Table 1).
Interestingly around 50% of these genes, represented
by HRAS, GANAB, CFL2, HSP90B1, HSP90AB1, GSN,
HSPA1L, NRAS, HSPA5, TIMP3, HYOU1, showed a
Fig. 4 C16-exo uptake and functional assays. a MNI cells were labeled with C16 and incubated for 24 h with ctr or pH 6.0 medium. C16-exo (ctr)
and (pH 6.0) were recovered and incubated at increasing doses for 2 h at 37 °C with MNI cells at pH 7.4. Cell fluorescence was analyzed by FACS.
The number of incorporated exosomes per cell was calculated and represented in the graph. Points: mean ± S.D. (n = 4). b and c Confocal
microscopy analysis of MNI cells after 2 h incubation with C16-exo (2 × 10
3 per cell) (ctr) (b) or (pH 6.0) (c). DAPI stains show the nucleus (blue).
Green: C16-exo. Scale bars, 10 μm. d Migration and invasion assays of MNI cells (3.5 × 104) after incubation with (10 × 106) C16-exo, deriving from
(ctr) or (pH 6.0) treated MNI cells. Migration and invasion were evaluated after 72 h of incubation by a colorimetric assay at 620 nm. * p < 0.05. e
and f Cell viability was assayed by trypan blue exclusion of dead cells. MNI cells (2 × 103) were incubated with C16-exo (ctr), (pH 6.7), (pH 6.0) (5 ×
106) and counted at the indicated days, or with 1 × 106, 5 × 106, 10 × 106 C16-exo (ctr), (pH 6.7), (pH 6.0) and counted after two days. Histograms:
means ± S.D. (n = 3). Results indicate that in e and f the differences among ctr and pH 6.0 are not statistically significant
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significant Mentel-Cox-p-value, i.e. a positive correlation
of their high expression in cancer tissues and poor prog-
nosis in patients with metastatic melanoma (Fig. 6a). A
subset of these genes was checked for gene expression
levels in MNI cells, and was found upregulated after
pH 6.0 treatment (Additional file 13).
This data was further confirmed by the expression of a
representative set of these genes, i.e. HSP90αβ, CFL,
GSN in exosomes released at acidic pH. Same amount
of control or acid exosomes was analyzed by western
blotting. As expected, the upregulation of all proteins
tested was evident in acid exosomes compared to con-
trol (Fig. 6b).
Finally, the expression levels of CFL, GSN and
HYOU1 proteins were evaluated on some representative
bioptic samples from melanoma patients. Interestingly, a
general increment of these proteins was observed in
lymph node autologous metastases compared with their
primary counterparts (Fig. 6c).
All together, these data indicate that molecular cargo
of exosomes released under microenvironmental acidity
mirrors the protein content of metastatic lesions.
This may suggest acid exosomes as a diagnostic tool of
poor prognosis in melanoma patients.
Discussion
To study molecular mechanisms involved in the early
steps of melanoma progression, we analyzed four differ-
ently staged human melanoma cell lines, reflecting melan-
oma progression, in the context of their most frequently
occurring microenvironmental change, i.e. pH acidifica-
tion. Microenvironmental acidic pH exerts multiple roles
in tumor advancement that imply local invasion and dis-
semination of cancer cell [44, 45], activation of MMPs
[46], and impairment of the immune response [47].
In the melanoma model, external low pH was found to
promote metastasis [5] and to affect exosome traffic [7].
An exosome functional role was principally described in
Fig. 5 Proteome characterization by HPLC-MS/MS of control and pH 6.0 exosome obtained after ultracentrifugation. a Venn diagram depicting
the overlap of upregulated and downregulated pH 6.0 proteins with respect to control condition. b Functional analysis of the downregulated,
equally expressed and upregulated proteins at pH 6.0. Only over-represented metabolic pathways with P ≤ 10− 2 were considered. c GO
enrichments of pH 6.0 upregulated proteins. Only over-represented categories with P≤ 10− 2 were considered
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the later stages of melanoma progression, being exo-
somes involved in the production of long-distance me-
tastases [12]. Nonetheless, a role of exosomes in driving
metastatic properties at intratumoral level under acidic
pressure was never defined so far.
A study on the effect of acidic pH variations has
already been performed, but it was limited to the de-
scription of the increase of exosome protein content [7].
In this paper thanks to a new cell labeling methodology
[18], we could monitor exosome amount through quan-
tification of intact particles under microenvironment pH
fluctuations, naturally occurring in metastatization
process.
To more closely reproduce in vitro such pH fluctuations,
we set up two experimental conditions, i.e. pH 6.7 and
pH 6.0. At these conditions, we monitored exosome release
among the plethora of extracellular vesicles secreted from
melanoma cells [48], by using a technique based on the
generation of nascent fluorescent vesicles of endosomal ori-
gin, considered bona fide exosomes (C16-exo) [18].
We definitely assessed that in MNI cell line culture at
acidic pH was recovered an increased number of vesicles
compared to that secreted at pH 7.4. This was not corre-
lated with intracellular pH variations, but was due to an
elevated exosome biosynthesis and reduced re-uptake.
This new labeling technique offered us an eligible and
innovative method for melanoma exosome detection
and analysis. In fact, we could estimate that the en-
hanced C16-exo secretion upon pH treatment was effect-
ive, and referable to small and intact structures.
In general, the increased amount of secreted exosomes
represents a hallmark of disease stage advancement.
However, in melanoma this issue was not completely
clarified, being reported in some studies an increased
amount of exosomes in plasma from advanced patients
[49, 50], and in other studies similar numbers of exo-
somes in patients at different clinical stages [12, 51].
To address this issue we monitored C16-exo secretion
from a panel of primary and metastatic melanomas. We
found: 1) a higher exosome number released by meta-
static than primary melanomas; 2) acidic pH increases
exosome release in melanoma at an intermediate stage
(i.e. not early primary or metastatic),
It is conceivable that increased extracellular availability
of exosomes at this stage is crucial for the progression of
the disease at a step in which the maximal spread of
newly acquired and specific molecular information are
needed to drive and sustain tumor aggressiveness. To
confirm such hypothesis, we tested the tumor promoting
role of acid released C16-exo on MNI cells. We found
that C16-exo released by MNI melanoma kept at low pH
exerted a pro-migratory and invasive role on autologous
pH naïve cells.
Interestingly, although control and acid exosomes are
greatly taken up by melanoma cells at extracellular acid
pHs, only those secreted at low pH are able to induce
into the less aggressive cells distinctive migratory and in-
vasive skills. This property can be maintained also after
long-term acid pH selection and re-acclimation at
pH 7.4, in line with the in vivo continuous acid
exposure.
Accordingly, a comparative proteomic analysis of exo-
somes released at pH 6.0 versus control, indicated in
acidic exosomes a general increment in the expression
of some protein categories as those belonging to focal
Table 1 Meta-analysis of upregulated protein in acid exosomes
through PrognoScan
Gene GenBank ID* Probe name Mentel-Cox
p-value**
HRAS 3265 212983_at 0.010599
IQGAP1 8826 213446_s_at NS
ACTN1 87 200601_at NS
ACTN4 81 208636_at NS
CDC42 998 214230_at NS
CFL1 1072 1555730_a_at NS
CFL2 1073 233496_s_at 0.002532
FN1 2335 210495_x_at NS
NRAS 4893 202647_s_at 0.002301
GSN 2934 202647_s_at 0.044629
VCL 7414 200930_s_at NS
CD44 960 229221_at NS
TIMP3 7078 201147_s_at 0.029350
THBS1 7057 201110_s_at NS
TLN1 7094 203254_s_at NS
CTNND1 1500 1557944_s_at NS
ICAM1 3383 215485_s_at NS
DNAJA2 10,294 209157_at NS
GANAB 23,193 214626_s_at 0.003695
HSP90AA1 3320 211968_s_at NS
HSP90B1 7184 216449_x_at 0.040481
HSP90AB1 3326 200064_at 0.029072
HSPA1L 3305 233694_at 0.048446
HSPA5 3309 230031_at 0.026684
HYOU1 10,525 200825_s_at 0.037596
VCP 7415 214990_at NS
*publicly accessible at https://www.ncbi.nlm.nih.gov/gene
**Numbers depict Mentel-Cox p values for gene expression with significant
difference in patient’s overall survival. Only values with p < 0.05 are indicated.
NS, patient’s overall survival not significant (p > =0.05) for the indicated high
or low gene expression. The analysis was performed by interrogating
PrognoScan database for gene expression in cancer tissue samples versus
overall survival rates of patients with metastatic melanoma. All the listed
genes refer to proteins involved in metastatic processes found upregulated in
acid exosomes (Additional file 12). The analysis has been performed by using
the dataset GSE19234, publicly accessible at GEO database [34]
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adhesion, actin cytoskeleton regulation, leukocyte
trans-endothelial migration, or more specifically to those
proteins governing the modification of cell morphology
such as small GTPase mediated signal transduction, and
regulating pro-migratory pathways such as EGFR.
Most of these molecules were already described in
metastatic exosomes [51], and some of them (HRAS,
GANAB, CFL2, HSP90B1, HSP90AB1, GSN, HSPA1L,
NRAS, HSPA5, TIMP3, HYOU1) were found upregu-
lated in patients with poor prognosis. Among this set of
genes, we here validated the higher expression of CFL,
GSN and HYOU1 in metastatic site with respect to au-
tologous primary tumor (patient with Clark’s level IV),
whereas Hsp90 protein overexpression was previously
described [52]. Altogether, these results highlight the
prognostic value of acid exosomes molecular cargo.
Due to the different nature of these molecules, i.e.
proto-oncogenes (HRAS, NRAS), metalloprotease
(TIMP3), heath shock protein isoforms (HSP90AB1,
HSP90B1, HSPAIL, HSPA5), enzyme (GANAB) involved
in protein folding and control in endoplasmic reticulum,
and actin-binding proteins (GSN, CFL2) regulating
reorganization of actin filaments, we can speculate inde-
pendent functional roles occurring in cell transform-
ation, and ultimately leading to enhanced cell
aggressiveness.
However, we can hypothesize a prominent role for
GSN and CFL in inducing cell migration. In fact, it is
feasible that both proteins, imported into recipient cells,
elicit actin cytoskeleton reorganization, thereby directly
modulating the migratory behavior of melanoma cells.
In melanoma progression a role of tumor surround-
ing normal cells, such as stromal or endothelial cells,
can not be excluded. In fact, exosomes released by
cancer cells are able to induce angiogenesis by trans-
ferring their content to endothelial cells [53–55], and
also trigger fibroblast differentiation into myofibro-
blast [56].
Moreover, exosomes derived from metastatic melan-
oma have been shown to facilitate the formation of
Fig. 6 Meta-analysis of significant metastatic upregulated proteins in acid exosomes through Prognoscan. a Kaplan-Meyer curves depicting the
Overall Survival of metastatic melanoma patients with high (red lines) or low (green lines) expression of the genes listed in Table 1 that resulted
statistically significant. Mentel-Cox p-values for each plot are showed. b Western blotting analysis of ctr and pH 6.0 exosomes (20 μg). Cell lysate
was used as positive control. Expression of CFL, GSN and HSP90αβ is shown. Ponceau red is shown for equal exosome protein amount. c
confocal immunofluorescence analysis with the indicated antibodies on primary (apical and mid region), and metastatic melanoma biopsies from
the same patient. Ki67 labeling was used as internal control. Red, CFL, GSN, HYOU1; blue, DAPI; green, Ki67. Bar 50 μm
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pre-metastatic niche by educating bone marrow derived
cells [12].
Thus, it is likely surmised that acid exosomes can play
a role also in remodeling a tumor microenvironment
through the conditioning of stromal cells, that may in-
duce microenvironmental adaptation and placement for
metastatic melanoma to take place. However, this study
will be the object of future work.
We here described a stage-specific melanoma
pro-invasive feature acquired from acid pH exposure,
and exerted through exosomes enriched in HRAS,
GANAB, CFL2, HSP90B1, HSP90AB1, GSN, HSPA1L,
NRAS, HSPA5, TIMP3, HYOU1 genes, that were statis-
tically related to melanoma patients poor prognosis.
The model system here proposed could be hypothe-
sized in vivo, i.e. within the heterogenic tumor mass,
where only some cells might initiate to highly produce
and disseminate exosomes in response to acidification,
so far influencing the behavior of neighboring cells.
Conclusions
Our findings contributes to a better understanding of
the role of exosomes in a specific stage of melanoma
progression driven by extracellular acidity. Overall, the
specific content of exosomes produced under acid con-
ditions may represent a melanoma stage-specific signa-
ture, which could be the object of new target therapies
against melanoma development.
Additional files
Additional file 1: Figure S1. Characterization of cell lines used in this
study. a Overview table depicting classification and gene mutations. b
Western blotting analysis of total cell lysates (20 μg/lane), with the
indicated antibodies. (PNG 369 kb)
Additional file 2: Figure S2. Experimental workflow of C16-exo isolation
from MNI cell culture. (PNG 271 kb)
Additional file 3: Additional Methods. (DOCX 22 kb)
Additional file 4: Figure S3. a MNI, and b EP cells phase contrast with
bounds of the selected cells (n = 30) for each condition. The lower
microphotographs depict the selected cells by means of the Region of
Interest (ROI, yellow lines) plugin of ImageJ. The selected cells were
analyzed for elongation and perimeter by the determination of Feret’s
diameter. (PNG 1662 kb)
Additional file 5: Figure S4. TLC analysis of fluorescent lipids of MNI
cells and exosomes. a Cells at the indicated pHs (above) and
quantification values (below) of each depicted peak (arrows) as
percentage value within each lane. b Exosomes at the indicated pHs
(above) and quantification values (below) of each depicted peak (arrows)
as percentage value within each lane. Sphingomyelin (SM), cardiolipin
(CL), phosphatidylserine (PS), phosphatidylinositol (PI),
phosphatidylethanolamine (PE), phosphatidylcholine (PC) and
bis(monoacylglycero)phospahate (BMP). (PNG 410 kb)
Additional file 6: Figure S5. MNI cells labeling with CFDA-SE, vesicles
isolation and FACS analysis. a MNI cells were left untreated, or pH 6.7,
and pH 6.0 treated for 22 h followed by 0.3 μM CFDA-SE labeling 5 min
at room temperature, then FACS analyzed. Bars: mean ± S.D. (n = 3). b
Workflow of vesicles isolation from MNI cells. Vesicles were labelled with
(10 μM) CFDA-SE for 1 h at room temperature to obtain CFSE-EV. c FACS
analysis of CFSE-EV population deriving from MNI cells cultivated at differ-
ent pHs. To design the R1 region above instrument background noise
only PBS was acquired. Note that no events were acquired in this region.
Histograms represent the green fluorescence intensity distribution of
events gated in R1 regions of CFSE population recovered from MNI cells
in standard culture condition (ctr), pH 6.7 and pH 6.0. (PNG 383 kb)
Additional file 7: Figure S6. MNI and MI intracellular expression of
exosome markers and intracellular pH (pHi) evaluation a-c. MNI, and d-f
MI cells were left untreated or pH 6.0 treated for the indicated times,
then cells were lysed and 30 μg/lane analyzed for Alix and Tsg101 by
western blot. a, d representative western blots are showed. b, e Alix, and
c, f Tsg101 expression were normalized against tubulin by densitometry
analysis and expressed as fold increase (n = 3),. g pHi measurement. Cells
were left untreated or incubated at pH 6.0. After 24 h intracellular pH was
measured with 3 μM BCECF-AM for 45 min at 37 °C. Mean ± s.d. (n = 3) *,
p < 0,05 **, p < 0,01. (PNG 485 kb)
Additional file 8: Figure S7. C16-exo uptake at extracellular acid pH.
17 × 106 C16-exo (ctr) and (pH 6.0) obtained from a MNI cells and c EP
cells, were incubated for 2 h at 37 °C with parental cells (0.05 × 106) at
the indicated pHs. The number of incorporated exosomes per cell was
calculated and represented as percentage of respective control at pH 7.4.
b C16-exo (ctr) and (pH 6.0) from EP cells were incubated at increasing
doses with EP cells at pH 7.4 for 2 h at 37 °C. Cell fluorescence was
analyzed by FACS and the number of transferred exosome calculated as
described in the text. Points: mean ± S.D. (n = 3). *, p < 0,05; **, p < 0,01;
***, p < 0,005 vs respective pH 7.4 condition; §§, p < 0,01 vs C16-exo ctr at
pH 7.4. (PNG 360 kb)
Additional file 9: Figure S8. MNI cells selection at acid pH. a Workflow
of MNI selection at acid pH. At the end of acclimation cells were assayed
for b growth, c morphology (magnification 10×) and d migration. MNI ctr
and MNI acid sel. C16-exo were obtained as described in the manuscript,
and same number (10 × 106) incubated for 72 h with MNI ctr cells. (n = 3)
*, p < 0.05. (PNG 596 kb)
Additional file 10: Table S1. Identification of exosomal markers in
melanoma exosomes by mass spectrometry. Table reporting the list of
identified exosomal proteins, according to the Exocarta database [39], in
control (ctr) or pH 6.0- exosomes from MNI cells. x, proteins identified.
(DOCX 17 kb)
Additional file 11: Table S2. List of exosomal proteins from MNI cells
identified by mass-spectrometry and found upregulated and down-
regulated at pH 6.0, or equally expressed in control condition. In case of
proteins specific for each condition emPAInorm value is reported. In case
of proteins found in both conditions emPAInorm ratio (ρ) is shown. (DOCX
59 kb)
Additional file 12: Table S3. pH 6.0 upregulated categories involved in
metastatic processes are indicated. Proteins found in these categories are
listed. (DOCX 15 kb)
Additional file 13: Figure S9. qRT–PCR in MNI ctr and pH 6.0 treated
(24 h) cells. Relative gene expression levels were normalized on GAPDH.
(PNG 158 kb)
Additional file 14: Additional References. (DOCX 17 kb)
Abbreviations
CFSE-EV: Extracellular vesicle labelled with CFDA-SE; C16: Bodipy FL-C16; C16-
exo: Exosome labelled with Bodipy FL-C16; CFL: Cofilin; EMT: Epithelial-
mesenchymal transition; EP: Early primary melanoma; ER: Endoplasmic
reticulum; EV: Extracellular vesicle; GANAB: Glucosidase II alpha subunit;
GSN: Gelsolin; HRAS: HRas proto-oncogene; HSP90AB1: Heat shock protein 90
alpha family class B member; HSPA5: Heat shock protein family A member 5;
HSPAIL: Heat shock protein family A member I like; HYOU1: Hypoxia up-
regulated protein 1; IHC: Immunohistochemistry; MI: Metastatic invasive
melanoma; MNI: Metastatic non -invasive melanoma; NRAS: Neuroblastoma
RAS viral oncogene homolog; PI: Primary invasive melanoma; TIMP3: Tissue
inhibitor of metalloproteinase 3
Acknowledgments
We thank M. Falchi for technical assistance in confocal microscopy and M.
Carollo for technical assistance in flow cytometry.
Boussadia et al. Journal of Experimental & Clinical Cancer Research  (2018) 37:245 Page 13 of 15
Funding
This work was supported by the Italian Ministry of Health (grant number RF-
2011-02347300).
Availability of data and materials
All data generated or analysed during this study are included in this
published article and its additional files, with the exception of the dataset
GSE19234, publicly accessible at GEO database (Gene Expression Omnibus
database, https://www.ncbi.nlm.nih.gov/geo), and regarding the meta-
analysis study through PrognoScan.
Authors’ contributions
ZB designed the work, analyzed and interpreted the data, prepared figures,
wrote the manuscript and developed the methodology. JL developed the
methodology, analyzed and interpreted the data. FFratini and LF acquired
and analyzed data about proteomic analysis. RP designed and performed
the immunohistochemistry analysis on bioptic samples. CZ, CR, KF, FFelicetti,
LP provided technical support and collected data. FM and EP prepared
tables and figure and realized database research. MSanchez developed the
methodology, acquired and interpreted Flow Citometry data. MSargiacomo
developed the methodology and revised the manuscript. AC revised the
manuscript. SD provided and prepared histological sections from melanoma
patient. IP designed the work, analyzed and interpreted the data, prepared
tables and figures, wrote the manuscript, and supervised the study. All
authors read and approved the final manuscript.
Ethics approval and consent to participate
The study was conducted in accordance with Good Clinical Practice
Guidelines and the Declaration of Helsinki. The study was also approved by
the IDI-IRCCS Ethics Committee (ID #407/1, 2013 and #407/2, 2016), and a




The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Global Health Center, Istituto Superiore di Sanità, Rome, Italy. 2Oncology
and Molecular Medicine Department, Istituto Superiore di Sanità, Rome, Italy.
3Major Equipments and Core Facilities, Istituto Superiore di Sanità, Rome,
Italy. 4National Center for the Control and Evaluation of Medicine, Istituto
Superiore di Sanità, Rome, Italy. 5Center for Gender- specific Medicine,
Istituto Superiore di Sanità, Istituto Superiore di Sanità, Rome, Italy.
6Laboratory of Molecular Oncology, Istituto Dermopatico dell’Immacolata-
IRCCS, Rome, Italy.
Received: 29 January 2018 Accepted: 24 September 2018
References
1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply,
and metabolic microenvironment of human tumors: a review. Cancer Res.
1989;49:6449–65.
2. Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to
the treatment of malignant disease. Radiother Oncol. 1984;2:343–66.
3. Fukamachi T, Ikeda S, Wang X, Saito H, Tagawa M, Kobayashi H. Gene
expressions for signal transduction under acidic conditions. Genes (Basel).
2013;4:65–85.
4. Moellering RE, Black KC, Krishnamurty C, Baggett BK, Stafford P, Rain M, et al.
Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp
Metastasis. 2008;25:411–25.
5. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH
promotes experimental metastasis of human melanoma cells in athymic
nude mice. Cancer Res. 2006;66:6699–707.
6. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ,
et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;
183:1161–72.
7. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, et al.
Microenvironmental pH is a key factor for exosome traffic in tumor cells. J
Biol Chem. 2009;284:34211–22.
8. Ekstrom EJ, Bergenfelz C, von Bulow V, Serifler F, Carlemalm E, Jonsson G, et
al. WNT5A induces release of exosomes containing pro-angiogenic and
immunosuppressive factors from malignant melanoma cells. Mol Cancer
2014;13:4598–13-88.
9. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, et al. Human tumor-
released microvesicles promote the differentiation of myeloid cells with
transforming growth factor-beta-mediated suppressive activity on T
lymphocytes. Cancer Res. 2006;66:9290–8.
10. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-
Bueno G, et al. Melanoma exosomes educate bone marrow progenitor
cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;
18:883–91.
11. Hood JL, Pan H, Lanza GM, Wickline SA. Consortium for translational research
in advanced imaging and nanomedicine (C-TRAIN). Paracrine induction of
endothelium by tumor exosomes. Lab Investig. 2009;89:1317–28.
12. Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare
sentinel lymph nodes for tumor metastasis. Cancer Res. 2011;71:3792–801.
13. Peppicelli S, Bianchini F, Torre E, Calorini L. Contribution of acidic melanoma
cells undergoing epithelial-to-mesenchymal transition to aggressiveness of
non-acidic melanoma cells. Clin Exp Metastasis. 2014;31:423–33.
14. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular
interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev
Biol. 2014;30:255–89.
15. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al.
Proteomic comparison defines novel markers to characterize heterogeneous
populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;
113:E968–77.
16. Willms E, Johansson HJ, Mager I, Lee Y, Blomberg KE, Sadik M, et al. Cells
release subpopulations of exosomes with distinct molecular and biological
properties. Sci Rep. 2016;6:22519.
17. Lai CP, Kim EY, Badr CE, Weissleder R, Mempel TR, Tannous BA, et al.
Visualization and tracking of tumour extracellular vesicle delivery and RNA
translation using multiplexed reporters. Nat Commun. 2015;6:7029.
18. Coscia C, Parolini I, Sanchez M, Biffoni M, Boussadia Z, Zanetti C, et al.
Generation, quantification, and tracing of metabolically labeled fluorescent
exosomes. Methods Mol Biol. 2016;1448:217–35.
19. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in
solid tumors in vivo: high-resolution measurements reveal a lack of
correlation. Nat Med. 1997;3:177–82.
20. WARBURG O. On the origin of cancer cells. Science. 1956;123:309–14.
21. Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, et
al. Focal adhesion kinase promotes the aggressive melanoma phenotype.
Cancer Res. 2005;65:9851–60.
22. Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, et al.
Inhibition of MEK sensitizes human melanoma cells to endoplasmic
reticulum stress-induced apoptosis. Cancer Res. 2007;67:9750–61.
23. Knutson JR, Iida J, Fields GB, McCarthy JB. CD44/chondroitin sulfate
proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell
migration on type IV collagen and invasion of basement membranes. Mol
Biol Cell. 1996;7:383–96.
24. Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-
analysis of the prognostic value of genes. BMC Med Genet. 2009;2:18.
25. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG, Gruenberg J. A
lipid associated with the antiphospholipid syndrome regulates endosome
structure and function. Nature. 1998;392:193–7.
26. Groot Kormelink T, Arkesteijn GJ, Nauwelaers FA, van den Engh G, Nolte-'t
Hoen EN, Wauben MH. Prerequisites for the analysis and sorting of
extracellular vesicle subpopulations by high-resolution flow cytometry.
Cytometry A. 2016;89:135–47.
27. Graham JM. Purification of lipid rafts from cultured cells.
ScientificWorldJournal. 2002;2:1662–6.
28. Yam XY, Birago C, Fratini F, Di Girolamo F, Raggi C, Sargiacomo M, et al.
Proteomic analysis of detergent-resistant membrane microdomains in
trophozoite blood stage of the human malaria parasite plasmodium
falciparum. Mol Cell Proteomics. 2013;12:3948–61.
Boussadia et al. Journal of Experimental & Clinical Cancer Research  (2018) 37:245 Page 14 of 15
29. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, et al.
Exponentially modified protein abundance index (emPAI) for estimation of
absolute protein amount in proteomics by the number of sequenced
peptides per protein. Mol Cell Proteomics. 2005;4:1265–72.
30. The DAVID Knowledgebase. https://david.ncifcrf.gov/. Accessed 5 Feb 2017.
31. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et
al. A rapid in vitro assay for quantitating the invasive potential of tumor
cells. Cancer Res. 1987;47:3239–45.
32. Niu J, Dorahy DJ, Gu X, Scott RJ, Draganic B, Ahmed N, et al. Integrin
expression in colon cancer cells is regulated by the cytoplasmic domain of
the beta6 integrin subunit. Int J Cancer. 2002;99:529–37.
33. The Prognoscan database: A new database for meta-analysis of the prognostic
value of genes. http://www.prognoscan.org/. Accessed 26 Oct 2017.
34. The Gene Expression Omnibus functional genomics data repository. https://
www.ncbi.nlm.nih.gov/geo. Accessed 22 Oct 2017.
35. Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, et al.
Simplified protocol for flow cytometry analysis of fluorescently labeled
exosomes and microvesicles using dedicated flow cytometer. J Extracell
Vesicles. 2015;4:25530.
36. Dutta S, Reamtong O, Panvongsa W, Kitdumrongthum S, Janpipatkul K,
Sangvanich P, et al. Proteomics profiling of cholangiocarcinoma exosomes:
a potential role of oncogenic protein transferring in cancer progression.
Biochim Biophys Acta. 2015;1852:1989–99.
37. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal
experimental requirements for definition of extracellular vesicles and their
functions: a position statement from the International Society for
Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
38. Vukovic V, Tannock IF. Influence of low pH on cytotoxicity of paclitaxel,
mitoxantrone and topotecan. Br J Cancer. 1997;75:1167–72.
39. Raghunand N, Gillies RJ. pH and drug resistance in tumors. Drug Resist
Updat. 2000;3:39–47.
40. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.
2011;144:646–74.
41. The Exocarta database. http://exocarta.org/exosome_markers. Accessed 12
Feb 2017.
42. Dror S, Sander L, Schwartz H, Sheinboim D, Barzilai A, Dishon Y, et al.
Melanoma miRNA trafficking controls tumour primary niche formation. Nat
Cell Biol. 2016;18:1006–17.
43. The Gene Ontology database. http://www.geneontology.org. Accessed 3
Mar 2017.
44. Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, et
al. Acidity generated by the tumor microenvironment drives local invasion.
Cancer Res. 2013;73:1524–35.
45. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, et al.
Bicarbonate increases tumor pH and inhibits spontaneous metastases.
Cancer Res. 2009;69:2260–8.
46. Fiaschi T, Giannoni E, Taddei ML, Cirri P, Marini A, Pintus G, et al. Carbonic
anhydrase IX from cancer-associated fibroblasts drives epithelial-
mesenchymal transition in prostate carcinoma cells. Cell Cycle. 2013;12:
1791–801.
47. Lardner A. The effects of extracellular pH on immune function. J Leukoc
Biol. 2001;69:522–30.
48. Muhsin-Sharafaldine MR, Saunderson SC, Dunn AC, Faed JM, Kleffmann T,
McLellan AD. Procoagulant and immunogenic properties of melanoma
exosomes, microvesicles and apoptotic vesicles. Oncotarget. 2016;7:56279–94.
49. Logozzi M, De Milito A, Lugini L, Borghi M, Calabro L, Spada M, et al. High
levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma
patients. PLoS One. 2009;4:e5219.
50. Alegre E, Sanmamed MF, Rodriguez C, Carranza O, Martin-Algarra S,
Gonzalez A. Study of circulating microRNA-125b levels in serum exosomes
in advanced melanoma. Arch Pathol Lab Med. 2014;138:828–32.
51. Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, et al.
Proteome characterization of melanoma exosomes reveals a specific signature
for metastatic cell lines. Pigment Cell Melanoma Res. 2015;28:464–75.
52. Huang SK, Darfler MM, Nicholl MB, You J, Bemis KG, Tegeler TJ, et al. LC/MS-
based quantitative proteomic analysis of paraffin-embedded archival
melanomas reveals potential proteomic biomarkers associated with
metastasis. PLoS One. 2009;4:e4430.
53. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression
of autocrine VEGF upon the uptake of tumor-derived microvesicles
containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009;106:3794–9.
54. Hong BS, Cho JH, Kim H, Choi EJ, Rho S, Kim J, et al. Colorectal cancer cell-
derived microvesicles are enriched in cell cycle-related mRNAs that
promote proliferation of endothelial cells. BMC Genomics 2009;10:556,2164–
10-556.
55. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al.
Glioblastoma microvesicles transport RNA and proteins that promote tumour
growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6.
56. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger
fibroblast to myofibroblast differentiation. Cancer Res. 2010;70:9621–30.
Boussadia et al. Journal of Experimental & Clinical Cancer Research  (2018) 37:245 Page 15 of 15
